Oncomine Dx Target Test DNA Control-IVD for detection of DNA and RNA isolated from non-small cell lung cancer (NSCLC) tumor specimens, Catalog Number: A32442.
Class I - DangerousWhat Should You Do?
- Check if you have this product: Lot Codes: S119_2174741 S119_2161574 P119_2149301 N119_2078113 S218_2069394 V118_1991153 T118_1990945 S217_2008383 S118_1988602 P118_1996941 S117_1988305 UDI: (01)10190302006095
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- Life Technologies Corporation
- Reason for Recall:
- Extended Expiration Date prior to clearance
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- terminated
Product Information
Full Description:
Oncomine Dx Target Test DNA Control-IVD for detection of DNA and RNA isolated from non-small cell lung cancer (NSCLC) tumor specimens, Catalog Number: A32442.
Product Codes/Lot Numbers:
Lot Codes: S119_2174741 S119_2161574 P119_2149301 N119_2078113 S218_2069394 V118_1991153 T118_1990945 S217_2008383 S118_1988602 P118_1996941 S117_1988305 UDI: (01)10190302006095
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: Z-1704-2020
Related Recalls
Torrent Suite Dx Software versions 5.14 and earlier used in connection with Ion PGM DX Systems exploitation of the vulnerability by a threat actor may allow them to alter settings, configurations, software, or data on the instrument
COVID-19 Interpretive Software issues that may cause: 1) the risk of invalid or inconclusive tests/false negative and potentially increasing the retesting burden on customers. 2) false positive results due to improper vortexing.
COVID-19 Interpretive Software issues that may cause: 1) the risk of invalid or inconclusive tests/false negative and potentially increasing the retesting burden on customers. 2) false positive results due to improper vortexing.